Alnylam Pharmaceuticals ALNY Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alnylam Pharmaceuticals's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alnylam Pharmaceuticals's earnings yield?
- Alnylam Pharmaceuticals (ALNY) reported earnings yield of 1.1% in Q1 2026.
- How has Alnylam Pharmaceuticals's earnings yield changed year-over-year?
- Alnylam Pharmaceuticals's earnings yield increased by 273.6% year-over-year, from -0.7% to 1.1%.
- What is the long-term trend for Alnylam Pharmaceuticals's earnings yield?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's earnings yield has grown at a -37.4% compound annual growth rate (CAGR), from -5.5% to 0.5%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.